Back to search
FDAFDA · Food and drugs·Recall number Z-1629-2024

TRIDENTII PSL CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 742-11-50D

Published May 1, 2024 · Recall initiated: February 27, 2024

Summary

FDA records medical device Class II recall Z-1629-2024, published May 1, 2024 and initiated February 27, 2024. Recalling firm: Howmedica Osteonics Corp.; Status: Ongoing; Reported quantity: 0; Lot: UDI-DI:(01)07613327381009(17)290313(10) Lot Number: 14593551 15432653 15432651. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The acetabular shell may have excessive deburring, resulting in a smooth surface on the edge of the shell

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Howmedica Osteonics Corp.
Distributor
Nationwide Foreign: Netherlands, Canada, Singapore, Spain, Sweden, UK
Lot
UDI-DI:(01)07613327381009(17)290313(10) Lot Number: 14593551 15432653 15432651
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was TRIDENTII PSL CLUSTER50D- Indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 742-11-50D recalled?

Yes. FDA published recall Z-1629-2024 on May 1, 2024. Reported hazard: The acetabular shell may have excessive deburring, resulting in a smooth surface on the edge of the shell

What should I do if I have this product?

Voluntary: Firm initiated · Letter